Drug Dev
BioPharm America™ 2017: NCI serves as a partner to advance drug development
Michael Salgaller is a supervisor in the National Cancer Institute's Tech Transfer office. At BioPharm America™ in Boston, he said he often ran into entrepreneurs and investors who were surprised to hear him talk about the NCI serving as a partner to advance drug development, not just a place to license intellectual property from.